Derek Stefureac has run at least one marathon on all 7 seven continents — and says it helps keep the "MS symptoms at bay" ...

Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting in Copenhagen this week is celebrating its 40th edition. In recognition of this landmark, the ...

This explanation challenges the results from previous randomised controlled trials and the efficacy of all approved drugs, ...

Communicating my experience with MS is important, columnist Ben Hofmeister says, but so is making sure the other person comprehends it.

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting ...

California is moving to address the cost of care with a new cap on health care cost increases that experts consider to be the most aggressive in the nation.

"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...

Novartis' new data for Kesimpta showed reduced disability progression in relapsing multiple sclerosis patients. Continuous ...

New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term ...

Bristol Myers Squibb & Co (NYSE:BMY) announced new data from the Phase 3 Daybreak trial demonstrating that decreased rates of ...

Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a ...